- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00232128
Protocol for Radiofrequency Ablation of Pulmonary Neoplasms
January 11, 2007 updated by: Oncology Specialties, Alabama
This research trial involves the development of a new treatment for lung tumors.
It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well to other forms of treatment.
This treatment uses a needle probe to deliver energy into the lung tumor.
This probe is placed utilizing a CT scan image.
The energy heats the tumor causing tumor cell death.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Huntsville, Alabama, United States, 35801
- Comprehensive Cancer Institute
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria: The patients enrolled in this study should be judged to have sufficient survival to benefit from control of local disease and include at least one of the following:
- unresectable primary or metastatic lung tumors
- may benefit from multiple modalities of therapy
- chemotherapeutic or radiation oncologic options have been exhausted
Exclusion Criteria:
1. co-existing morbidities that preclude the use of surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Marshall T. Schreeder, M.D., Comprehensive Cancer Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2003
Study Registration Dates
First Submitted
October 3, 2005
First Submitted That Met QC Criteria
October 3, 2005
First Posted (Estimate)
October 4, 2005
Study Record Updates
Last Update Posted (Estimate)
January 12, 2007
Last Update Submitted That Met QC Criteria
January 11, 2007
Last Verified
May 1, 2006
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCI LUN 02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Neoplasms
-
Chang Gung Memorial HospitalNational Science Council, TaiwanCompletedPulmonary Neoplasms | Solitary Pulmonary NodulesTaiwan
-
University of Colorado, DenverNational Cancer Institute (NCI); University of Kentucky; University of Louisville and other collaboratorsNot yet recruitingLung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer, Lung | Cancer of the Lung | Pulmonary Neoplasm | Lung Cancers | Neoplasm, Pulmonary | Cancers, Lung | Cancer, Pulmonary | Cancers, Pulmonary | Pulmonary Cancers
-
China-Japan Friendship HospitalRecruitingPulmonary Nodules, Solitary | Pulmonary Nodules, MultipleChina
-
GuiBin QiaoActive, not recruitingPulmonary Nodule, Solitary | Pulmonary Nodule, MultipleChina
-
Peking University People's HospitalUnknownPulmonary Nodule, Solitary | Pulmonary Nodule, MultipleChina
-
University Medical Center GroningenRecruitingPulmonary Nodules, SolitaryNetherlands
-
Brigham and Women's HospitalCompletedPulmonary Nodule, Solitary | Pulmonary Nodule, MultipleUnited States
-
Tongji HospitalCompletedLung Cancer | Segmentectomy | Pulmonary Nodule, Solitary | Pulmonary Nodule, MultipleChina
-
University of OxfordOptellum Ltd.CompletedLung Cancer | Pulmonary Nodule, Solitary | Pulmonary Nodule, MultipleUnited Kingdom
-
RenJi HospitalNot yet recruitingPulmonary Nodule, Solitary | Pulmonary Nodule, Multiple
Clinical Trials on Radiofrequency Ablation of pulmonary neoplasms
-
Hangzhou Broncus Medical Co., Ltd.Shanghai Chest HospitalRecruitingStage IA Lung CancerChina
-
Hangzhou Broncus Medical Co., Ltd.CompletedLung Neoplasms | Pulmonary MetastasisChina
-
University Hospital TuebingenCompletedLung Cancer | Lung MetastasisGermany
-
Texas Cardiac Arrhythmia Research FoundationCompletedMigraine | Atrial FibrillationUnited States
-
Ohad ZivBiosense Webster, Inc.RecruitingAtrial Fibrillation - SymptomaticUnited States
-
University of California, San DiegoCompletedParoxysmal Atrial Fibrillation | Atrial ArrhythmiaUnited States
-
University of PittsburghCompletedPostoperative Atrial FibrillationUnited States
-
University of PennsylvaniaCompletedAtrial FibrillationUnited States
-
Instituto de investigación e innovación biomédica...Active, not recruitingAtrial Fibrillation, PersistentSpain
-
French Cardiology SocietyCompletedCardiovascular Diseases | Atrial Fibrillation, PersistentFrance